Chargement en cours...
Promising New Agents for Colorectal Cancer
There are many exciting new therapies being developed for mCRC patients. Beyond adding to existing combination backbones of chemotherapy with oxaliplatin and irinotecan, subsets of mCRC patients have been identified who may benefit from novel treatments such as immune checkpoint blockade, HER2 inhib...
Enregistré dans:
| Publié dans: | Curr Treat Options Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6499928/ https://ncbi.nlm.nih.gov/pubmed/29752549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-018-0543-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|